Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series

J Clin Immunol. 2023 Aug;43(6):1067-1071. doi: 10.1007/s10875-023-01480-0. Epub 2023 Apr 24.

Authors

Marie-Lee Simard¹, Marc-Antoine Nadeau², Amélie Gauthier², Guilhem Cros³, Aubert Lavoie²

Affiliations

¹ Department of Clinical Immunology and Allergy, CHU de Québec, Laval University, Quebec, QC, Canada. marie-lee.simard.1@ulaval.ca.
² Department of Clinical Immunology and Allergy, CHU de Québec, Laval University, Quebec, QC, Canada.
³ Institut de Recherches Cliniques de Montréal, CHUM, University of Montreal, Montreal, QC, Canada.

No abstract available

Publication types

Letter

MeSH terms

Agammaglobulinemia* / complications
Agammaglobulinemia* / diagnosis
Antibodies, Monoclonal / therapeutic use
COVID-19*
Genetic Diseases, X-Linked* / complications
Genetic Diseases, X-Linked* / diagnosis
Genetic Diseases, X-Linked* / genetics
Humans

Substances

Antibodies, Monoclonal

Supplementary concepts

Bruton type agammaglobulinemia